First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study (Q83904901)
Jump to navigation
Jump to search
scientific article published on 12 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study |
scientific article published on 12 April 2012 |
Statements
First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study (English)
Christoph Thomssen
Jean-Yves Pierga
Kathleen I Pritchard
Hernan Cortes-Funes
Katarína Petráková
Bella Kaufman
Anja Duenne
12 April 2012